The views of Alzheimer disease patients and their study partners on proxy consent for clinical trial enrollment

American Journal of Geriatric Psychiatry

Volumn 16, Issue 3, 2008, Pages 240-247

  Karlawish, Jason ^a,g   Kim, Scott Y H ^b   Knopman, David ^c   Van Dyck, Christopher H ^d   James, Bryan D ^e   Marson, Daniel ^f  

^a University School of Medicine   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MAYO CLINIC ROCHESTER   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f The University of Alabama at Birmingham   (United States)

^g NONE   (United States)

Author keywords

Informed consent; Proxy consent; Research ethics

Indexed keywords

PLACEBO; SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATTITUDE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; DISEASE COURSE; FEMALE; HUMAN; INFORMED CONSENT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; NEUTRON RADIATION; PATIENT PARTICIPATION; RANDOMIZED CONTROLLED TRIAL; RESEARCH ETHICS; RESEARCH SUBJECT; WELLBEING; CAREGIVER; CROSS-SECTIONAL STUDY; ETHICS; MENTAL HEALTH; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGICAL ASPECT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATTITUDE; CAREGIVERS; CROSS-SECTIONAL STUDIES; ETHICS, RESEARCH; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PATIENT PARTICIPATION; RESEARCH SUBJECTS; SIMVASTATIN; THIRD-PARTY CONSENT;

EID: 44649186234     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e318162992d     Document Type: Article

References (15)

1. Sachs GA, Stocking CB, Stern R, et al: Ethical aspects of dementia research: informed consent and proxy consent. Clin Res 1994; 42:403-412
2. Warren JW, Sobal J, Tenney JH, et al: Informed consent by proxy: an issue in research with elderly patients. N Engl J Med 1986; 315:1124-1128
3. Muncie HL Jr, Magaziner J, Hebel R, et al: Proxies' decisions about clinical research participation for their charges. J Am Geriatr Soc 1997; 45:929-933
4. Buchanan AE, Brock DW: Deciding for Others: The Ethics of Surrogate Decision Making. Cambridge, Cambridge University Press, 1989
5. Wendler D, Martinez RA, Fairclough D, et al: Views of potential subjects toward proposed regulations for clinical research with adults unable to consent. Am J Psychiatry 2002; 159:585-591
6. Kim SY, Kim HM, McCallum C, et al: What do people at risk for Alzheimer disease think about surrogate consent for research? Neurology 2005; 65:1395-1401
7. Stocking CB, Hougham GW, Danner DD, et al: Speaking of research advance directives: planning for future research participation. Neurology 2006; 66:1361-1366
8. Stocking CB, Hougham GW, Baron AR, et al: Are the rules for research with subjects with dementia changing? Views from the field. Neurology 2003; 61:1649-1651
9. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34:939-944
10. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
11. Appelbaum PS, Grisso T: The MacArthur Competence Assessment Tool-Clinical Research. Sarasota, FL, Professional Resources Press, 2000
12. National Bioethics Advisory Commission. Research Involving Persons With Mental Disorders That May Affect Their Decision Making Capacity. Vol I. Report and Recommendations. Rockville, MD, U.S. Government Printing Office, 1998
13. Karlawish JHT, Casarett D, Klocinksi J, et al: How do AD patients and their caregivers decide whether to enroll in a clinical trial? Neurology 2001; 56:789-792
14. Black BS, Kass NE, Fogarty LA, et al: Informed consent for dementia research: the study enrollment encounter. IRB 2007; 29: 7-14
15. Hirschman KB, Joyce CM, James B, et al: Would caregivers of Alzheimer's disease (AD) patients involve their relative in a decision to use an AD slowing medication? Am J Geriatr Psychiatry 2005; 13:1014-1021